SCHEMBL25833574

SCHEMBL25833574

CCc1ccc2c(-c3ccccc3-c3ccccc3)nc(C(C)(C)C)nc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.37
PRNP P04156 2/20 0.37
MAPT P10636 5/20 0.37
LMNA P02545 3/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
PLA2G1B P04054 1/20 0.37
ATG4B Q9Y4P1 1/20 0.37
CNR1 P21554 3/20 0.35
CNR2 P34972 3/20 0.35
ELANE P08246 2/20 0.34
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
PGK1 P00558 1/20 0.33
MAPK1 P28482 1/20 0.33
PSMB5 P28074 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2A6 P11509 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25817444 0.83 SCD (0.38) ALDH1A1MAPTLMNAL3MBTL1PLA2G1B
SCHEMBL18232172 0.82 ALDH1A1 (0.44) ALDH1A1PRNPMAPTLMNAL3MBTL1
SCHEMBL25878131 0.71 ALDH1A1 (0.37) ALDH1A1MAPTLMNAL3MBTL1PLA2G1B
SCHEMBL16520903 0.70 ADORA2A (0.55) ALDH1A1MAPTLMNAL3MBTL1PLA2G1B
SCHEMBL20052625 0.68 MEN1 (0.40) ALDH1A1MAPTLMNARAB9ASMN1; SMN2
SCHEMBL19161955 0.68 ALDH1A1 (0.44) ALDH1A1PRNPMAPTLMNAL3MBTL1
SCHEMBL25877827 0.68 ADORA2A (0.43) ALDH1A1PRNPMAPTLMNAL3MBTL1
SCHEMBL18232171 0.68 ADORA2A (0.51) ALDH1A1MAPTLMNAL3MBTL1PLA2G1B
SCHEMBL19161957 0.67 ALDH1A1 (0.40) ALDH1A1PRNPMAPTLMNAL3MBTL1
SCHEMBL18232159 0.67 ADORA2A (0.46) ALDH1A1PRNPMAPTLMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217825-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217825-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME OR10J3, AOC2, EPCAM ALDH1A1 489/4885PRNP 2829/4885MAPT 1654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.